If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

Share Price is delayed by 15 minutes
Get Live Data
55.00    1.70 (3.19%)
Bid:
54.70
Ask:
55.10
Spread: 0.40 (0.731%)
Market Cap: £348.12m
MARS Live PriceLast checked at - London Stock Exchange

Intraday Marstons Share Chart

AGM And Trading Statement

27 Jan 2015 07:00

RNS Number : 1692D
Marston's PLC
27 January 2015
 

 

27 January 2015

MARSTON'S PLC

AGM AND TRADING STATEMENT

 

Marston's issues the following Trading Statement for the 16 week period to 24 January 2015 in advance of the Company's Annual General Meeting to be held at noon today.

 

Trading

Our performance in the financial year to date has been encouraging, including good trading over the Christmas and New Year period. Profitability is in line with our expectations.

 

In Destination and Premium, like-for-like sales were 2.0% ahead of last year with both food and drink like-for-like sales growth of 2.0%. In the key two week Christmas trading period to 4 January trading was particularly strong with growth of 4.8%, including 12.5% growth on Christmas Day. Operating margins are ahead of last year and our plans to open at least 25 new-pub restaurants in the current financial year are on track, with eight openings expected in the first half.

 

In Taverns, managed and franchise pub like-for-like sales were 2.0% ahead of last year, with 2.7% growth over the Christmas fortnight and 5.8% growth on Christmas Day. Our franchise model continues to prove successful, providing motivated licensees with local flexibility and reduced risk while improving the quality, consistency and value of the consumer offer.

 

In Leased, profits were around 1% ahead of last year.

 

In Brewing, performance has been strong with Group Ale volumes up 4% in the year to date, underpinned by a very strong performance in the off-trade, with volumes up 8%. Hobgoblin, our biggest brand, continues to perform well, with volumes up 10% in the year to date.

 

We will announce our Interim Results for the 26 weeks to 4 April 2015 on 14th May 2015.

 

Commenting, Ralph Findlay, Chief Executive, said:

"We have again traded well over the Christmas period, with good sales growth over the key Christmas fortnight for the third year in succession, including serving a record 60,000 meals on Christmas Day. This performance demonstrates that our customers remain attracted to the consistency and value for money we offer, underpinned by excellent service in a high quality environment. In addition, our Beer business continues to perform well, with a particularly strong performance in the off-trade. We remain confident of achieving our expectations for the full year."

 

 

ENQUIRIES:

Marston's PLC Tel: 01902 329516

Ralph Findlay, Chief Executive Officer

Andrew Andrea, Chief Financial Officer

 

 

Instinctif Partners Tel: 020 7457 2020

Justine Warren

Matthew Smallwood

 

 

 

 

NOTES TO EDITORS

Marston's is a leading pub operator and independent brewer.

It has an estate of around 1,700 pubs situated nationally, comprising managed, franchised and leased pubs.

It is the UK's leading brewer of premium cask and bottled ales, including Marston's Pedigree and Hobgoblin. The beer portfolio also includes Banks's, Jennings, Wychwood, Ringwood, Brakspear and Mansfield beers.

Marston's employs around 13,000 people.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTPGUCUGUPAGMQ
Date   Source Headline
1st Nov 20181:25 pmRNSTotal Voting Rights
12th Oct 20184:07 pmRNSHolding(s) in Company
10th Oct 20187:00 amRNSYEAR END TRADING UPDATE
1st Oct 20183:21 pmRNSTotal Voting Rights
21st Sep 20183:04 pmRNSHolding(s) in Company
20th Sep 201810:21 amRNSHolding(s) in Company
19th Sep 20188:12 amRNSDirector Declaration
17th Sep 20189:57 amRNSDirector/PDMR Shareholding
6th Sep 20187:00 amRNSAppointment of Chairman
5th Sep 20182:00 pmRNSHolding(s) in Company
21st Aug 20189:07 amRNSHolding(s) in Company
14th Aug 20189:29 amRNSHolding(s) in Company
7th Aug 201812:23 pmRNSDirector/PDMR Shareholding
2nd Aug 20188:46 amRNSDirector Declaration
31st Jul 20187:30 amRNSDirector Declaration
25th Jul 20182:15 pmRNSDirector Declaration
25th Jul 20187:00 amRNSTrading Update
19th Jul 20188:47 amRNSDirector Declaration
10th Jul 20181:38 pmRNSBlock listing Interim Review
3rd Jul 20182:19 pmRNSDirector/PDMR Shareholding
2nd Jul 20182:48 pmRNSTotal Voting Rights
2nd Jul 20189:27 amRNSDirector/PDMR Shareholding
21st Jun 20189:57 amRNSHolding(s) in Company
19th Jun 20183:21 pmRNSDirector/PDMR Shareholding
19th Jun 201811:07 amRNSHolding(s) in Company
12th Jun 201810:13 amRNSDirector/PDMR Shareholding
6th Jun 20181:18 pmRNSDirector/PDMR Shareholding
5th Jun 20187:00 amRNSStatement re analyst site visit
23rd May 201812:09 pmRNSDirector/PDMR Shareholding
16th May 20187:00 amRNSInterim Results for 26 weeks ended 31 March 2018
11th May 201812:38 pmRNSAppointment of Interim Chairman
16th Apr 20189:51 amRNSHolding(s) in Company
3rd Apr 201811:01 amRNSTotal Voting Rights
15th Mar 20187:00 amRNSDirectorate Change
15th Mar 20187:00 amRNSAppointment of Chairman
21st Feb 20184:01 pmRNSHolding(s) in Company
6th Feb 20182:12 pmRNSDirector/PDMR Shareholding
24th Jan 20189:53 amRNSResult of AGM
23rd Jan 20187:00 amRNSTrading update for the 16 weeks to 20 January 2018
10th Jan 201810:07 amRNSBlock listing Interim Review
2nd Jan 20183:54 pmRNSDirector/PDMR Shareholding
2nd Jan 20182:25 pmRNSTotal Voting Rights
20th Dec 20179:42 amRNSDirector Declaration
20th Dec 20177:00 amRNSWilliam Hill appoints Chairman Designate
18th Dec 20174:27 pmRNSAnnual Financial Report
12th Dec 20174:27 pmRNSDirector/PDMR Shareholding
12th Dec 20174:25 pmRNSDirector/PDMR Shareholding
5th Dec 20172:02 pmRNSDirector/PDMR Shareholding
1st Dec 201711:44 amRNSTotal Voting Rights
30th Nov 20177:00 amRNSPreliminary Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.